38677-85-9Relevant articles and documents
Polymorphism in the Anti-inflammatory Drug Flunixin and Its Relationship with Clonixin
Camargo, Hernando A.,Contreras, Jines E.,Dávila-Miliani, María Cecilia,Díaz De Delgado, Graciela,Delgado, José Miguel,Dugarte-Dugarte, Analio,Henao, José Antonio,Toro, Robert A.
, p. 4657 - 4666 (2020)
Crystallization of the nonsteroidal anti-inflammatory drug (NSAID) flunixin in acetone and in acetone-hexane produced two conformational polymorphs, as predicted by hydrogen-bond propensity analyses, which are similar to three of the polymorphs of the rel
Preparation method of flunixin meglumine
-
Paragraph 0022-0024; 0026-0037; 0042-0045; 0054-0057, (2019/01/24)
The invention discloses a preparation method of flunixin meglumine the preparation method, and the method specifically comprises the following steps: (1) adding 2-chloronicotinic acid and 2-methyl-3-trifluoromethyl aniline into a sodium hydroxide water solution for stirring, adding ethylene glycol as well as a phase transfer catalyst and p-toluenesulfonic acid and copper oxide, controlling the temperature and time, adjusting the pH value of the solution, stirring, standing, layering, stirring, filtering, washing filter cake, and drying to obtain flunixin; and (2) reacting the flunixin obtainedin the step (1) with N-methylglucosamine in isopropyl alcohol, and meanwhile, adding a filler; carrying out heating reflux, filtering, cooling, stirring and crystallizing, carrying out crystal suction filtration, and washing crystals with isopropanol to obtain the flunixin meglumine. The preparation method of the flunixin meglumine is convenient and simple in operation, the reflecting efficiencyis high, the reaction temperature is low, the reaction time is short, and the cost is low; moreover, the prepared flunixin meglumine is high in purity and high in yield.
Process for preparing flunixin and intermediates thereof
-
, (2008/06/13)
Process for preparing a key intermediate, 2-methyl-3-trifluoromethylaniline (MTA) of Flunixin, as well as novel intermediates thereof are described.